By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Van Andel Research Institute (VARI) has started a new pediatric cancer research program that will focus on using molecular analysis and personalized medical approaches, VARI said today.

The VARI Pediatrics Cancer Translational Research Program will use genomic techniques to develop treatments for children with cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.